ClinicalTrials.gg
CompletedNCT07432646Updated Mar 10, 2026

"Finding Solid Ground" in Inpatient Treatment for Dissociative Disorder Patients Followed by Transition to Outpatient Treatment Settings: A 1-year Follow-up Pilot Study

An observational study in Dissociative Identity Disorder, Dissociative Disorder Not Otherwise Specified (DDNOS) and PTSD and Trauma-related Symptoms, sponsored by Modum Bad. Completed at 1 site in Norway. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-03-10.

Sponsored by Modum Bad · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
30
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The purpose of the pilot is to examine the usefulness of the psychoeducational program, Finding Solid Ground, for patients with dissociative disorders in a naturalistc observational study, involving a 3-months inpatient treatment followed by patients continuation with the program in their local outpatient settings, by examining outcome of main trauma-related symptoms and adaptive coping. In addition, performing focus-group interviews with the patient groups at discharge and at follow-up, to gain information on their subjective experiences from participating in the program. The patients' therapists in the outpatient settings are invited to give written feedback on their experiences from working with FSG.

Read the detailed description

Adult survivors of childhood trauma have complex and diverse symptoms profiles. A subgroup develop a complex dissociative disorder. Modum Bad has for years offered a 3-months inpatient treatment program for this patient group. Patients leave the hospital after this treatment period and continue with treatment in their local outpatient settings. They come back for a 5-days follow-up 9 months after discharge from the residential setting. The aim of the pilot study is to examine changes in posttraumatic and dissociative symptoms and adaptive coping in this patient-group within the described naturalistic context, following patients' participation in Finding Solid Ground (FSG). FSG is developed by dr Bethany Brand, dr. Hygge Schielke, and dr Ruth Lanius (2022), and designed for this patient-group. It has 30 topics. Patients start up with FSG and complete 8 topics in the inpatient setting, and are offered to continue with the remaining topics during the outpatient period in collaboration with local treatment providers. 32 patients were recruited. Two of them were not included: one did not want to participate, and the other patient had a different focus in her treatment than FSG. Patients were assigned from referrals to the residential Department for Trauma treatment, Modum Bad, in Norway. As part of the usual clinical practice they were referred to our treatment group if they had a complex dissociative disorder in need of stabilization. The inpatient treatment lasts for 11 weeks and combines group- and individual therapies with different treatment modalities, all within the framework of FSG. Patients came back for a 5-days follow-up stay, 9 months after discharge from the inpatient treatment.

02

Conditions studied

  • Dissociative Identity Disorder
  • Dissociative Disorder Not Otherwise Specified (DDNOS)
  • PTSD and Trauma-related Symptoms

Keywords

  • childhood trauma
  • inpatient
  • outpatient
  • dissociation
  • selfcompassion
  • emotion regulation
03

In context

Stress Disorders, Post-Traumatic

2,682 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 601 are open to participants now.

This study's enrollment of 30 is below the median of 150 across 371 observational studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

Modum Bad is the lead sponsor of 19 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

They are selected from patients referred to treatment in the Department for Trauma Treatment, Modum Bad, and have been routinely evaluated for treatment in this department, diagnosed with a dissociative disorder and in need of stabilisational interventions.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The study include adults (minimum age of 18 years) with a complex dissociative disorder related to childhood trauma. All patients had received outpatient therapy with insufficient effect. Patients were diagnosed with at dissociative disorder, transformed to the ICD-10 dissociative disorders.

Exclusion criteria

Exclusion Criteria:

  • Ongoing psychosis, severe ongoing drug addiction, very disturbed group functioning, ongoing severe life crisis, mental disability, severe unsafe behavior (suicidality, self-harm).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
30 participants (actual)
Target follow-up
12 Months
Patient registry
Yes

Groups and cohorts

  • Adults with compelx dissociative disorders and histories of childhood trauma

    All group and individual therapies were in line with the model presented in Finding Solid Ground, developed by dr. Bethany Brand et al. (2022). Patients were admitted for the inpatient pre-planned treatment for a 3-months period, continue with therapy in their local outpatient settings after discharge from the inpatient period, and come back for a 5-days follow-up stay 9 months after discharge from the inpatient treatment.

    Behavioral: Psychotherapy

Interventions

  • BehavioralPsychotherapy

    Patients are admitted in groups of eight. During the 3-months inpatient treatment period, the program include a daily group session, and 3 weekly individual sessions with individual therapists and milieu-therapists, with focus on FSG-interventions from a trauma- and dissociation-informed perspective. FSG follows the international guidelines (ISSTD, 2011) for treatment of dissociative disorders from the International Society for the Study of Trauma and Dissociation. It uses different treatment modalities, such as live psychoeducation, psychoeducational videos, written and practical exercises, equine facilitated therapy, reflection and discussion groups. They have parallel individual therapy with therapist (psychiatrist or psychologist) and milie-therapists, and participate in physical activity and ward meetings together with other patients in the unit. All therapists are trained in trauma- and dissociation therory and treatment, as well as the FSG model.

06

What researchers measure

Primary outcomes

  1. Progress in Treatment Questionnaire (PITQ-p)

    Asesses adaptive capacities. It has 32 items scored on an 11-point scale ranging from 0% to 100%. Scores are averaged. Higher scores indicate higher capacitiy for adaptive coping.

    Time frame: at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)

  2. PTSD Checklist for DSM-5 (PCL-5)

    Posttraumaticstress disorder checklist for DSM-5, scale and subscales. Sum scores range from 20-80, with higher scores indicating greater PTSD symptoms severity

    Time frame: assessmentsat respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)

  3. Difficulties in emotion regulation scale (DERS)

    Difficulties in emotion regulation scale, scale and subscales. It has 36 items ranging from 1 to 5. Scores are averaged. Higher scores indicate higher level of difficulties in emotion regulation.

    Time frame: assessments at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)

  4. Self-compassion Scale - Short Form (SCS-SF)

    Self-compassion scale short form (SCS-SF) has 12 items ranging from 1 to 5. Scores are averaged. Total average socres are calculated after reverse scoring of relevant items, with higher scores indicating higher level of self-compassion.

    Time frame: assessments at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)

  5. Dissociative Experiences Scale (DES-II)

    Dissociative experiences scale - version II has 28 items ranging from 0% to 100%. Scores are averaged. Higher scores indicate higher levels of dissociation.

    Time frame: assessments at respectively: baseline (T1); 3 months (T2); and 1-year follow-up (T3)

Secondary outcomes

  1. Hedonic deficits and interference scale (HDIS)

    Includes three subscales; 1) Positive emotionality (PE); 2) Hedonic deficits (HD); 3) Negative affective interference (NAI). All subscales are scored on a scale of 1 to 10. The scores are averaged. PE has 5 items, a higher score indicates higher levels of PE; HD has 5 items, a higher score indicates higher levels of HD; NAI has 11 items, a higher score indicates higher levels of negative affective interference.

    Time frame: Assessment at respectively: 1) baseline (T1); 2) 3-months (T2); and 3) 1-year follow-up.

07

Study locations

1 site
  • Modum Bad, Psychiatric clinic
    Vikersund, Buskerud 3370, Norway
08

References and documents

Publications

  • Pierorazio, N. A., Robertson, J. L., Snyder,B. L., Brand, J. Schielke, H. J., & Lanius, R. A. (2025). Helpful aspects of a psychoeducational program for individuals with complex dissociation: An update for the Finding Solid Ground program. https://doi.org/10.1016/j.ejtd.2025.100566

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2023 to primary completion in Jun 2025, 24 months.

Of 142 non-industry observational studies under Stress Disorders, Post-Traumatic, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 59. This study's 24 months is below that.

Counting every sponsor, half of 149 studies reached it within 34 months; a quarter within 14 and three quarters within 54.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 17, 2025
First posted
Feb 25, 2026
StartActual
Jun 1, 2023
Primary completionActual
Jun 10, 2025
CompletionActual
Jun 10, 2025
Last update
Mar 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07432646
Lead sponsor
Modum Bad
Responsible party
Sponsor
First posted
Feb 25, 2026
Start date
Jun 1, 2023
Primary completion
Jun 10, 2025
Completion
Jun 10, 2025
Last update
Mar 10, 2026

Study contacts

Peter Sele, PhD candidate
study director · Modum Bad, Research Institute, Vikersund, Buskerud, Norway

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion